The Journal of
Clinical Psychiatry

Mood Disorders

Original Research November 15, 2003

Successful Treatment With Clozapine at Higher Doses After Clozapine-Induced Priapism

Alexander de Nesnera, MD

J Clin Psychiatry 2003;64(11):1394-1395

Article Abstract

Letter to the Editor

Successful Treatment With Clozapine at Higher Doses After Clozapine-Induced Priapism.

Buy PDF for $40.00

Please sign in or purchase this PDF for $40.00.

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 85 • 2024 • Number 4

Read the Current Issue

Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

Systematic Review

Diagnostic Assessment via Telehealth vs Face-to-Face

Original Research

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Original Research

Bridge Symptoms Between Borderline Personality and PTSD

Original Research

Gepirone-ER and Sexual Function in Patients with MDD

Original Research

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

View current Issue

Original Research

Transdiagnostic PRS Prediction of Mood Disorders

April 20, 2022

Mood disorders often co-occur with behavior disorders in children and adolescents. This study explored if polygenic risk scores based on external genome-wide association studies of these disorders could improve...

Eric J. Barnett , Joseph Biederman , Alysa E. Doyle , et al

Original Research

Mood Stabilizers and Placenta-Mediated Complications

June 18, 2019

Women who take mood stabilizers have a greater risk of placenta-mediated pregnancy complications. But are the mood stabilizers themselves responsible for this higher risk? This study explores that question.

Jacqueline M. Cohen , Krista F. Huybrechts , Elisabetta Patorno , et al

Original Research

Long-Term Remission With Cariprazine in Patients With Schizophrenia

January 8, 2019

When treating patients with schizophrenia, achieving stable, long-term remission is an important step toward the goal of functional recovery. This study evaluated the effect of cariprazine on several measures...

Christoph U. Correll , Steven G. Potkin , Yan Zhong , et al

Successful Treatment With Clozapine at Higher Doses After Clozapine-Induced Priapism

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

ELSEWHERE:

FOLLOW US:

Successful Treatment With Clozapine at Higher Doses After Clozapine-Induced Priapism

Read the Current Issue

Changes in Cognition in Patients With Schizophrenia

Diagnostic Assessment via Telehealth vs Face-to-Face

Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans

Bridge Symptoms Between Borderline Personality and PTSD

Gepirone-ER and Sexual Function in Patients with MDD

Medication Use and Lines of Treatment in Patients With Insomnia Disorder

Related Articles

Transdiagnostic PRS Prediction of Mood Disorders

Mood Stabilizers and Placenta-Mediated Complications

Long-Term Remission With Cariprazine in Patients With Schizophrenia

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles